e-novex' proprietary electronic data capture (EDC) technology is widely adopted by pharmaceutical, biotech and medical device companies, CROs, academic research organizations (ARO) and individual researchers. The portfolio comprises of e-capture.net for approval studies and the disruptive technology edc2go, which allows building an electronic case report form (eCRF) in a matter of hours instead of weeks or months. The core lab tracker platform facilitates the management and tracking of image logistics and enables secure transfer of large image data sets.
"The purchase of e-novex further increases genae's capacity to provide electronic solutions to our customers in the medical industries. The acquisition also is expected to result in greater eHealth efficiencies and in significantly increasing our capabilities in data management and risk based monitoring," said Bart Segers, CEO of genae.
The entire e-novex staff will be integrated in genae's eSolutions business unit, which already includes data management and statistics efficiencies. There will be no disruptions of e-novex' services during the integration, which will take place over the next three months.